GEN Exclusives

More »
New Products

Related to Roche Ups Bid for Illumina to $51 Per Share, or $6.5B

    • Sequencing System
    • Pacific Biosciences
    • The PacBio RS II allows scientists to generate finished genome assemblies, reveal and understand epigenomes, and characterize genomic variation. Based on the SMRT sequencing technology, the RS II can generate average read lengths of 5,000 base pair
    • Library Quantification Kit
    • Bio-Rad
    • Used with the QX100™ Droplet Digital™ PCR system, the ddPCR™ library quantification kit lets researchers directly measure amplifiable library concentrations. The TruSeq sample preparation method is the technique behind Illumina’s MiSeq and HiSeq ne
    • Purification Column for Histidine-Tagged Proteins
    • Roche
    • The cOmplete His-Tag Purification Column for researchers performing histidine-tagged protein purification from lysates uses nickel-chelate chemistry and is compatible with reducing agents such as dithiothreitol, metalloproteinase-inhibiting reagent
    • Kits for Analyzing Modified Cytosines
    • Cambridge Epigenetix
    • TrueMethyl™ kits provide quantitative, accurate and repeatable single-base resolution sequencing of the modified bases hydroxymethylcytosine (5-hmC) and methylcytosine (5-mC) in genomic DNA. This capability is attributable to the kits’ utiliza
    • Sugar Transferase for Glycoproteins
    • Roche
    • An alpha-2,6-sialyltransferase is available for in vitro sialylation of glycoproteins and complex molecules in the form of human monoclonal antibodies. The enzyme, which is offered for research and pilot-scale applications in biopharmaceutical manu
  • Page 1 of 1 (5 items) 1 

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?